Manuel Aleixandre

Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease

Antón Álvarez, Ramón Cacabelos, Carolina Sanpedro et al. · Neurobiology of Aging · 2006 · 277 citations

Life Sciences, Immunology, Neuroscience +16

A 24‐week, double‐blind, placebo‐controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

X.A. Alvarez, R Cacabelos, M. Laredo et al. · European Journal of Neurology · 2006 · 98 citations

Medicine, Neurology, Pharmacology +15

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double‐blind, controlled trial investigating three dosages of Cerebrolysin

X.A. Alvarez, Ramón Cacabelos, Carolina Sampedro et al. · European Journal of Neurology · 2010 · 70 citations

Medicine, Neurology, Pharmacology +13

Combination Treatment in Alzheimers Disease: Results of a Randomized, Controlled Trial with Cerebrolysin and Donepezil

X.A. Alvarez, Ramón Cacabelos, Carolina Sampedro et al. · Current Alzheimer Research · 2011 · 65 citations

Medicine, Pharmacology, Pharmacotherapy +17

Apathy and APOE4 are associated with Reduced BDNF Levels in Alzheimer's Disease

Antón Álvarez, Manuel Aleixandre, Carlos Sánchez‐Linares et al. · Journal of Alzheimer s Disease · 2014 · 61 citations · Full text

Life Sciences, Neurology, Neuroscience +17